Directory

CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Our technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Our miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

Seashell Technology LLC is a privately held San Diego-based nanotechnology company. Seashell Technology was formed by President and co-founder Dr. Sheldon Schultz who has had over 20 years experience working and developing nanocomposite materials and novel metamaterials. Since its inception in 1996 Seashell Technology has developed plasmon resonant particles for use as optically observable biological labels, and for other applications.

We at BioCure are committed to be a leading company in the dynamic healthcare market.

We are dedicated to serve the medical community and the patients under their care by providing product solutions to treat many medical conditions where today's therapies are either deficient or non-existent.

Our vision is to create strong, product-focused collaborations with leading commercialization partners in the fields of medical devices and biotechnology.

SPECS leads the way in state-of-the-art technology, cutting-edge components and individually designed complex systems for surface analysis.

SPECS forms a team of scientists and engineers with more than 100 employees engaged in the design and production of instruments for nanotechnology, material science and surface science in general.

For now over 25 years, know-how, experience, intensive contact to scientists from all over the world, customer orientation and reliable quality control have been the keys to SPECS success.

The Sanofi Pasteur VaxDesign Campus designs, develops, and manufactures in vitro models of the human immune system. Our mission is to prevent infectious disease by forecasting vaccine responses before clinical trials, and create a competitive advantage by providing predictive in vitro immunological models and assays.

TGN’s business strategy involves both short- and long-term objectives that will generate revenue in the present and facilitate future R & D. TGN continues to generate revenue from the sales of custom nanoparticles and Nanogene™ reagents and Federal and State grant-funding mechanisms for small businesses to support R & D. TGN plans to develop and market diagnostic reagents/kits for the detection of viral infections, including AIDS, and the early detection of cancers.

Sinmat’s CMP technologies are based on the company’s unique expertise in creating engineered slurries, mixtures of nano-particles and chemicals that smooth out rough topographies and create defect-free surfaces in a rapid, reliable, and cost-effective manner. Such CMP processes are applied to a wide variety of materials and device systems such as silicon and compound semiconductors, and other advanced materials.

RAVE LLC was registered in August of 1996 by founders Victor Kley (General Nanotechnology LLC), Frank Lundy (Technical Instruments San Francisco), and Barry Hopkins (RAVE LLC CEO), to implement the use of AFM equipment technology in a revolutionary new approach for repairing extremely small defects on critical level advanced photomasks.

Radiation Shield Technologies (RST) is the world leader in the research, design and production of personal protection systems for ionizing and nuclear radiation. The company's core technology, Demron™ , is specifically engineered to combine radiation protection with "ease of use" in order to maximize effective radiological defense.

Quantachrome is a world leader in the design and manufacture of laboratory instruments for characterizing properties of porous materials and powders.